Correction to - Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma - long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy

Sep 29, 2026

Uploaded by Levi

Correction notice for a published Annals of Hematology article on carfilzomib, lenalidomide and dexamethasone (KRD) in relapsed-refractory multiple myeloma, reporting long-term follow-up from a multicenter retrospective real-life survey by the European myeloma network (EMN) Italy. The correction addresses an authorship/name listing error: the original article incorrectly reported the surname as “Fabro” and the first name as “Vittorio Del.” The accurate name is “Del Fabro” as surname and “Vittorio” as first name. The notice confirms the original article has been corrected and includes licensing and publisher statements.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages2

Reading Time5 min

AccessFree to download

Correction

Correction details (author name)

Licensing and publisher statements

Original article reference

Annals of Hematology (2025) 104:6473–6474 [https://doi.org/10.1007/s00277-025-06713-3](https://doi.org/10.1007/s00277-025-06713-3) CORRECTION Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy Correction to: annals of hematology Concetta Conticello1 · Vittorio Del Fabro2 · Alessandra Romano1,3 · Anna Mele4 · Roberto Mina5 · Sara Bringhen6 · Alessandra Orofino3 · Elisabetta Antonioli7 · Stefano Pulini8 · Lorenzo De Paoli9 · Tommaso Za10 · Emilia Cotzia11 · Federica Elia1 · Andrea Casson5 · Eleonora Prete4 · Stefania Citiso4 · Carmine Liberatore12 · Gloria Margiotta-Casaluci13 · Francesca Fazio14 · Sonia Morè15 · Irene Attucci7 · Fabrizio Accardi16 · Velia Bongarzoni17 · Silvia Mangiacavalli18 · Elena Rossi10 · Donato Mannina19 · Bruno Garibaldi1 · Rita Rizzi20 · Monica Di Cecca21 · Bernardino Rossini22 · Giuseppina Uccello23 · Cirino Botta24 · Dario Leotta3 · Donatella Vincelli25 · Massimo Gentile26,27 · Alfonso Piciocchi28 · Giovanni Marsili28 · Francesca Patriarca29 · Renato Zambello30 · Pellegrino Musto20 · Mario Boccadoro31,32 · Massimo Offidani15 · Maria Teresa Petrucci14 · Francesco Di Raimondo1,3 Published online: 13 November 2025 © The Author(s) 2025 Correction to: Annals of Hematology [https://doi.org/10.1007/s00277-025-06602-9](https://doi.org/10.1007/s00277-025-06602-9) . In the published paper, the article incorrectly lists the lastname as Fabro and the first name as Vittorio Del. The correct last name is Del Fabro and the correct first name is Vittorio. The original article has been corrected. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) . Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The original article can be found online at [https://doi.org/10.1007/s00](https://doi.org/10.1007/s00)[ ](https://doi.org/10.1007/s00)277-025-06602-9. Extended author information available on the last page of the article Authors and Affiliations Concetta Conticello1 · Vittorio Del Fabro2 · Alessandra Romano1,3 · Anna Mele4 · Roberto Mina5 · Sara Bringhen6 · Alessandra Orofino3 · Elisabetta Antonioli7 · Stefano Pulini8 · Lorenzo De Paoli9 · Tommaso Za10 · Emilia Cotzia11 · Federica Elia1 · Andrea Casson5 · Eleonora Prete4 · Stefania Citiso4 · Carmine Liberatore12 · Gloria Margiotta-Casaluci13 · Francesca Fazio14 · Sonia Morè15 · Irene Attucci7 · Fabrizio Accardi16 · Velia Bongarzoni17 · Silvia Mangiacavalli18 · Elena Rossi10 · Donato Mannina19 · Bruno Garibaldi1 · Rita Rizzi20 · Monica Di Cecca21 · Bernardino Rossini22 · Giuseppina Uccello23 · Cirino Botta24 · Dario Leotta3 · Donatella Vincelli25 · Massimo Gentile26,27 · Alfonso Piciocchi28 · Giovanni Marsili28 · Francesca Patriarca29 · Renato Zambello30 · Pel

FAQs

What was corrected in the published Annals of Hematology paper?

The paper incorrectly listed the author name as lastname “Fabro” and first name “Vittorio Del.” The corrected name is lastname “Del Fabro” and first name “Vittorio.”

Which study is this correction related to?

It relates to a study on KRD (carfilzomib, lenalidomide, and dexamethasone) for relapsed-refractory multiple myeloma, with long-term follow-up from a multicenter retrospective real-life survey by EMN Italy.

Has the original article been updated?

Yes. The correction notice states that the original article has been corrected.

Sep 29, 2026

Uploaded by Levi